Nuoya Bio-engineering

Nuoya Bio-engineering is a biotechnology company based in Hangzhou, China, that operates at the intersection of advanced biomaterials and innovative drug development. The company is widely recognized for its expertise in chitosan-based medical devices, including high-performance hemostatic dressings and surgical sutures used in regenerative medicine. In recent years, the company has expanded into the oncology space through its biotech arm, Noah Biotech, which focuses on the development of next-generation oncolytic virus therapies. Its lead candidate, NB-001, is an engineered oncolytic Herpes Simplex Virus type 1 (HSV-1) currently in Phase 1 clinical trials for the treatment of advanced solid tumors. Nuoya Bio-engineering maintains a strong R&D focus, supported by a postdoctoral research station and collaborations with leading academic institutions.